Author:
Li Yanfei,Li Tingting,Jin Yueling,Shen Junwei
Funder
National Nature Science Foundation of China
Shanghai university of medicine & health sciences
Young Teacher Training Program of Shanghai Municipal Education Commission
fund program of Shanghai university of medicine & health Sciences
Subject
Pharmacology,General Medicine
Reference25 articles.
1. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma;Ouyang;Sci. Rep.,2018
2. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017
3. Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial;Cainap;J. Clin. Oncol.,2015
4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
5. Hepatocellular carcinoma;Forner;Lancet,2018
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献